 |
Tobramycin for inhalation |
|---|---|
| Trade Name | Tobi |
| Orphan Indication | Cystic fibrosis |
| USA Market Approval | USA |
| USA Designation Date | 1994-10-13 00:00:00 |
| Sponsor | Novartis Pharmaceuticals Corp;Drug Regulatory Affairs, One Health Plaza;East Hanover, New Jersey, 07936 |
Related Access Program